loader image

SGPI 2026

2nd International Symposium on Inborn Errors of Immunity of the Serbian Group for Primary  Immunodeficiencies

Support from institutions, associations and organizations

Agenda SGPI Symposium

2nd International Symposium on Inborn Errors of Immunity of the Serbian Group for Primary Immunodeficiencies

Day One - Novi Sad

24th April 2026 (09:30-16:00)
Chamber of Commerce and Industry of Vojvodina,
Braće Popović Street 5, Novi Sad, Serbia
Nikola Tesla Hall
(Registration of Participants 09:30 – 09:50)
Welcome and Opening Remarks (SGPI/SPwPID) 09:50 – 10:00

Day Two – Belgrade

25th April 2026 (08:30-17:30)
Yugoslav Film Archive, Uzun Mirkova Street 1, Belgrade, Serbia
(Registration of Participants 08:30 – 08:50)
Welcome and Opening Remarks (SGPI/SPwPID) 08:50 – 09:00

Sponsors of the SGPI 2026 Symposium

Gold Sponsors

Silver Sponsor

Bronze Sponsors

Friends of the Symposium

About Us

SGPI

The Serbian Group for Primary Immunodeficiencies (SGPI) was established in 2019, initially based in Niš, under the expert leadership of Professor Goran Marjanović from the University Clinical Center Niš. The association was founded with a clear goal: to improve the recognition, diagnosis, and treatment of primary immunodeficiencies (PID) in Serbia.

In August 2024, a new presidency and Board of Directors were elected, with the current headquarters in Belgrade. We launched new development directions and further strengthened SGPI as a national platform for comprehensive action in the field of Inborn Errors of Immunity (IEI), as PID are currently classified.

Today, SGPI brings together an increasing number of active and honorary members and serves as a hub for continuous professional development, knowledge exchange, and the advancement of clinical practice.

What We Strive For

Mission

The mission of the Serbian Group for Primary Immunodeficiencies is to improve the recognition, diagnosis, and treatment of primary immunodeficiencies in Serbia.

Mission

The mission of the Serbian Group for Primary Immunodeficiencies is to improve the recognition, diagnosis, and treatment of primary immunodeficiencies in Serbia.

Vision

The long-term vision of SGPI is a society where patients with PID are timely recognized, properly managed, and treated with access to modern and personalized therapy.

Vision

The long-term vision of SGPI is a society where patients with PID are timely recognized, properly managed, and treated with access to modern and personalized therapy.

Goal

Connecting experts and enhancing multidisciplinary collaboration through education, research, and professional guidelines.

Goal

Connecting experts and enhancing multidisciplinary collaboration through education, research, and professional guidelines.
News

Abstract Submission for SGPI 2026

We invite you to actively participate in the scientific program of the Congress and submit your abstract! The best abstracts, as evaluated by the expert committee, will be selected for

News

ESID 4th PID Care in Development (PIDCD) School

From 11–13 December 2025, the fourth Primary Immunodeficiency (PID) Care in Development School was held in Split, Croatia. This school is intended for physicians and researchers who wish to expand